We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
226
DELISTED
Merus
MRUS
$610K 0.06%
14,517
+1,398
+11% +$67.1K
HSAI
227
Hesai Group
HSAI
$2.99B
$608K 0.06%
44,000
+14,500
+49% +$102K
KHC icon
228
Kraft Heinz
KHC
$29.1B
$604K 0.06%
19,678
+4,342
+28% +$142K
TJX icon
229
TJX Companies
TJX
$169B
$600K 0.06%
4,970
+3,970
+397% +$474K
FOLD
230
DELISTED
Amicus Therapeutics
FOLD
$597K 0.06%
63,358
+6,314
+11% +$65.6K
JANX icon
231
Janux Therapeutics
JANX
$1.02B
$596K 0.06%
11,128
+1,095
+11% +$57.9K
TWST icon
232
Twist Bioscience
TWST
$7.85B
$585K 0.05%
12,586
+1,318
+12% +$59.6K
GEHC icon
233
GE HealthCare
GEHC
$32.6B
$581K 0.05%
7,435
+1,643
+28% +$140K
CCEP icon
234
Coca-Cola Europacific Partners
CCEP
$47.3B
$575K 0.05%
7,492
+1,667
+29% +$129K
BHVN icon
235
Biohaven
BHVN
$2.17B
$575K 0.05%
+15,396
New +$718K
VCEL icon
236
Vericel Corp
VCEL
$2.29B
$575K 0.05%
10,466
+1,036
+11% +$52.4K
PEN icon
237
Penumbra
PEN
$12.9B
$573K 0.05%
+2,414
New +$549K
SWTX
238
DELISTED
SpringWorks Therapeutics
SWTX
$570K 0.05%
15,773
+1,488
+10% +$52K
VERA icon
239
Vera Therapeutics
VERA
$2.16B
$568K 0.05%
13,427
+2,882
+27% +$128K
LEGN icon
240
Legend Biotech
LEGN
$3.99B
$564K 0.05%
17,320
+1,609
+10% +$66.6K
KYMR icon
241
Kymera Therapeutics
KYMR
$9.48B
$552K 0.05%
13,733
+1,311
+11% +$59.2K
RXRX icon
242
Recursion Pharmaceuticals
RXRX
$1.76B
$547K 0.05%
80,943
+28,038
+53% +$189K
EWTX icon
243
Edgewise Therapeutics
EWTX
$4.73B
$536K 0.05%
20,077
+2,042
+11% +$65K
TTWO icon
244
Take-Two Interactive
TTWO
$45.4B
$526K 0.05%
2,858
+635
+29% +$110K
DEO icon
245
Diageo
DEO
$52.2B
$523K 0.05%
4,117
– –
AMRX icon
246
Amneal Pharmaceuticals
AMRX
$6.15B
$520K 0.05%
+65,698
New +$551K
DXCM icon
247
DexCom
DXCM
$34.3B
$512K 0.05%
6,580
+1,274
+24% +$94.3K
DYN icon
248
Dyne Therapeutics
DYN
$4.89B
$508K 0.05%
21,575
+2,265
+12% +$67K
DPZ icon
249
Domino's
DPZ
$11.7B
$506K 0.05%
1,206
-1,211
-50% -$529K
NAMS icon
250
NewAmsterdam Pharma
NAMS
$3.33B
$503K 0.05%
+19,589
New +$416K
8 9
10
11 12

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.